Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Karnon

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
A trial-based cost-effectiveness analysis of letrozole followed by tamoxifen versus tamoxifen followed by letrozole for postmenopausal advanced breast cancerJ Karnon, S R D Johnston, T Jones, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2018
A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)S Ishaque, J Karnon, G Chen, et al.
Health Technology Assessment (Winchester, England)|November 19, 2010
Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancerC Czoski-Murray, J Karnon, R Jones, et al.
Health Technology Assessment (Winchester, England)|May 19, 2004
Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysisJ Karnon, J Peters, J Platt, et al.
Health Technology Assessment (Winchester, England)|June 3, 2008
The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluationJ Carlton, J Karnon, C Czoski-Murray, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 14, 2024
Adaptation and content validation of measure yourself medical outcomes profile (MYMOP) for 7-11 year-old childrenS Ishaque, R M Roberts, J Karnon, et al.
Current Medical Research and Opinion|April 29, 2008
Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United KingdomJ Karnon, K Tolley, J Oyee, et al.
Health Policy (Amsterdam, Netherlands)|May 16, 2018
Mortality reductions from marginal increases in public spending on healthL C Edney, H Haji Ali Afzali, T C Cheng, et al.
Journal of Public Health Medicine|February 24, 2001
The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: a modelling approachJ Karnon, D Zeuner, A E Ades, et al.
Clinical and Laboratory Haematology|February 15, 2000
Lifetime treatment costs of beta-thalassaemia majorJ Karnon, D Zeuner, J Brown, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
A trial-based cost-effectiveness analysis of letrozole followed by tamoxifen versus tamoxifen followed by letrozole for postmenopausal advanced breast cancerJ Karnon, S R D Johnston, T Jones, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2018
A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)S Ishaque, J Karnon, G Chen, et al.
Health Technology Assessment (Winchester, England)|November 19, 2010
Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancerC Czoski-Murray, J Karnon, R Jones, et al.
Health Technology Assessment (Winchester, England)|May 19, 2004
Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysisJ Karnon, J Peters, J Platt, et al.
Health Technology Assessment (Winchester, England)|June 3, 2008
The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluationJ Carlton, J Karnon, C Czoski-Murray, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 14, 2024
Adaptation and content validation of measure yourself medical outcomes profile (MYMOP) for 7-11 year-old childrenS Ishaque, R M Roberts, J Karnon, et al.
Current Medical Research and Opinion|April 29, 2008
Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United KingdomJ Karnon, K Tolley, J Oyee, et al.
Health Policy (Amsterdam, Netherlands)|May 16, 2018
Mortality reductions from marginal increases in public spending on healthL C Edney, H Haji Ali Afzali, T C Cheng, et al.
Journal of Public Health Medicine|February 24, 2001
The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: a modelling approachJ Karnon, D Zeuner, A E Ades, et al.
Clinical and Laboratory Haematology|February 15, 2000
Lifetime treatment costs of beta-thalassaemia majorJ Karnon, D Zeuner, J Brown, et al.
Pageof 4